Skip to main content
. 2014 Dec 17;125(5):873–880. doi: 10.1182/blood-2014-10-606491

Table 3.

Comparison of hepcidin and hepcidin-ferritin ratio among iron-replete individuals with and without heterozygous β-gene mutations

Normal population (N = 176) β-thalassemia trait (N = 82) HbE trait (N = 19) P for difference between normal and β thalassemia trait P for difference between normal and HbE trait
Hemoglobin* 15.2 (13.0-19.7) 12.0 (9.6-17.6) 13.3 (11.4-17.2) <.001 <.001
Ferritin 39.7 (15.5-240.7) 39.5 (15.4-205.5) 40.9 (17.9-94.4) .960 .806
sTfR 25.7 (10.4-93.2) 35.8 (18.3-95.2) 20.0 (11.0-32.7) <.001 .003
Serum iron* 17.3 (2.8-33.7) 15.7 (2.7-30.5) 14.7 (5.7-26.1) .036 .071
Hepcidin 5.1 (1.2-44.6) 4.1 (1.1-25.4) 5.24 (4.0-6.8) .007 .837
Hepcidin-ferritin ratio 0.13 (0.02-0.82) 0.10 (0.02-0.44) 0.13 (0.05-0.69) .011 .997
*

Arithmetic means (range); P values calculated from Student t test between arithmetic means of normal and individuals with heterozygote β-gene mutations of interest.

Geometric means (range); P values calculated from Student t test between log-transformed means of normal and individuals with heterozygote β-gene mutations of interest.